ARCHIVES

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Research Needed On Hormonally Active Agents, Report Finds

August 6, 1999

NCI Announces New Grant Programs In Preventions, Smoking, Alcohol; 1980 Applications Due March 1

January 11, 1980

Search Committee Sends Short List For NCI Director To HHS, White House

April 7, 1995

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment

August 26, 1988

BSA Approves Six Concepts

July 19, 2013